4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001140361-18-009074
Interim CEO acquired 15,211 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Quinn Anthony G. · Interim CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-02-15 | Exercise or conversion : show line 1 in the form | +15,211 | $5.46 | $83,052 | 50,620 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-02-15 | Exercise or conversion : show line 2 in the form Director Stock Option (right to buy) | −15,211 | 8,598 | D |
Loading xslF345X03/doc1.xml…